Brief: 9 Meters Biopharma Reports Q2 Loss Per Share Of $0.03
Aug 12 (Reuters) - 9 Meters Biopharma Inc NMTR.O :
* Q2 LOSS PER SHARE $0.03
* CASH AS OF JUNE 30, 2021 OF $64 MILLION EXPECTED TO
PROVIDE
SUFFICIENT CASH RUNWAY INTO 2023 BASED ON CURRENT OPERATING PLAN
Further company coverage: NMTR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on 9 Meters Biopharma
See all newsIllumina cuts annual profit forecast as biotech funding woes linger (updated)
Illumina cuts annual profit forecast
U.S. STOCKS ON THE MOVE-Pieris Pharma, Microsoft, Energy sector
U.S. STOCKS ON THE MOVE-Medtronic, Morgan Stanley, Bank of America
9 Meters Biopharma falls after filing for bankruptcy protection